For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Astera Labs Inc (NASDAQ: ALAB) was $161.55 for the day, down -19.03% from the previous closing price of $199.53. In other words, the price has decreased by -$19.03 from its previous closing price. On the day, 17.43 million shares were traded. ALAB stock price reached its highest trading level at $184.0 during the session, while it also had its lowest trading level at $160.14.
Ratios:
Our analysis of ALAB’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 25.19 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 127.65. For the most recent quarter (mrq), Quick Ratio is recorded 10.55 and its Current Ratio is at 11.10. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, BofA Securities on October 03, 2025, initiated with a Neutral rating and assigned the stock a target price of $230.
On October 01, 2025, TD Cowen started tracking the stock assigning a Hold rating and target price of $200.
Northland Capital Downgraded its Outperform to Market Perform on July 22, 2025, while the target price for the stock was maintained at $120.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 01 ’25 when Mazzara Philip sold 10,000 shares for $192.16 per share. The transaction valued at 1,921,572 led to the insider holds 151,573 shares of the business.
ALBA MANUEL sold 183,000 shares of ALAB for $31,707,713 on Sep 02 ’25. The Director now owns 385,863 shares after completing the transaction at $173.27 per share. On Aug 28 ’25, another insider, Mazzara Philip, who serves as the General Counsel and Secretary of the company, sold 10,000 shares for $188.70 each. As a result, the insider received 1,886,956 and left with 161,573 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALAB now has a Market Capitalization of 33165707264 and an Enterprise Value of 25819922432. As of this moment, Astera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 283.27, and their Forward P/E ratio for the next fiscal year is 76.80. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.36. For the stock, the TTM Price-to-Sale (P/S) ratio is 44.34 while its Price-to-Book (P/B) ratio in mrq is 23.64. Its current Enterprise Value per Revenue stands at 42.639 whereas that against EBITDA is 553.517.
Stock Price History:
The Beta on a monthly basis for ALAB is 1.48, which has changed by 1.463028 over the last 52 weeks, in comparison to a change of 0.13724327 over the same period for the S&P500. Over the past 52 weeks, ALAB has reached a high of $262.90, while it has fallen to a 52-week low of $47.12. The 50-Day Moving Average of the stock is -19.04%, while the 200-Day Moving Average is calculated to be 37.03%.
Shares Statistics:
ALAB traded an average of 6.11M shares per day over the past three months and 7061860 shares per day over the past ten days. A total of 166.21M shares are outstanding, with a floating share count of 127.25M. Insiders hold about 23.45% of the company’s shares, while institutions hold 61.12% stake in the company. Shares short for ALAB as of 1759190400 were 8989174 with a Short Ratio of 1.47, compared to 1756425600 on 9206501. Therefore, it implies a Short% of Shares Outstanding of 8989174 and a Short% of Float of 7.359999999999999.
Earnings Estimates
Astera Labs Inc (ALAB) is presently subject to a detailed evaluation by 15.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $0.42, with high estimates of $0.46 and low estimates of $0.39.
Analysts are recommending an EPS of between $1.62 and $1.55 for the fiscal current year, implying an average EPS of $1.58. EPS for the following year is $2.09, with 17.0 analysts recommending between $2.88 and $1.8.
Revenue Estimates
It is expected that $90B in revenue will be generated in . The current quarter, according to 14 analysts. It ranges from a high estimate of $208.1M to a low estimate of $201.52M. As of . The current estimate, Astera Labs Inc’s year-ago sales were $113.09MFor the next quarter, 14 analysts are estimating revenue of $216.49M. There is a high estimate of $222.3M for the next quarter, whereas the lowest estimate is $209.58M.
A total of 17 analysts have provided revenue estimates for ALAB’s current fiscal year. The highest revenue estimate was $805M, while the lowest revenue estimate was $762.47M, resulting in an average revenue estimate of $776.46M. In the same quarter a year ago, actual revenue was $396.29MBased on 16 analysts’ estimates, the company’s revenue will be $1.04B in the next fiscal year. The high estimate is $1.29B and the low estimate is $972.5M.
